| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 95.917.627 $ | +7.781.551 $ | +15,5 % | 10 | 88.990.498 $ | +32.382.397 $ | +103,9 % | 9 | 58.366.348 $ | +17.772.939 $ | +85,3 % | 6 | ||||
| KLA CORP | KLAC | → 0 | Neutral | 29.275.928 $ | +2.686.332 $ | +10,1 % | 1 | 26.589.596 $ | +2.986.592 $ | +12,7 % | 1 | 23.603.004 $ | +9.407.316 $ | +66,3 % | 1 |
| BRISTOL MYERS SQUIBB CO | BMY | → 0 | Stark | 18.575.154 $ | +2.239.857 $ | +13,7 % | 1 | 16.335.297 $ | +2.045.723 $ | +14,3 % | 1 | 14.289.574 $ | -678.646 $ | -4,5 % | 1 |
| Compass Therapeutics, Inc. | CMPX | → 0 | Neutral | 7.754.436 $ | -799.641 $ | -9,3 % | 1 | 8.554.077 $ | +5.498.794 $ | +180,0 % | 1 | ||||
| Stoke Therapeutics, Inc. | STOK | → 0 | Neutral | 6.837.600 $ | -1.414.800 $ | -17,1 % | 1 | 8.252.400 $ | +3.317.400 $ | +67,2 % | 1 | 4.935.000 $ | +2.551.500 $ | +107,0 % | 1 |
| LAM RESEARCH CORP | LRCX | → 0 | Sehr stark | 7.691.760 $ | +788.242 $ | +11,4 % | 1 | 6.903.518 $ | +6.903.518 $ | 1 | |||||
| Olema Pharmaceuticals, Inc. | OLMA | → 0 | Neutral | 6.725.000 $ | +5.021.540 $ | +294,8 % | 1 | ||||||||
| Ovintiv Inc. | OVV | → 0 | Stark | 6.381.200 $ | +2.168.275 $ | +51,5 % | 1 | ||||||||
| Structure Therapeutics Inc. | GPCR | → 0 | Neutral | 4.820.000 $ | -1.439.500 $ | -23,0 % | 1 | 6.259.500 $ | +4.075.500 $ | +186,6 % | 1 | ||||
| Intellia Therapeutics, Inc. | NTLA | → 0 | Neutral | 5.710.028 $ | +2.874.582 $ | +101,4 % | 1 | ||||||||
| CORCEPT THERAPEUTICS INC | CORT | → 0 | Neutral | 5.584.992 $ | +652.512 $ | +13,2 % | 1 | ||||||||
| PROTHENA CORP PUBLIC LTD CO | PRTA | → 0 | Neutral | 4.364.465 $ | +152.734 $ | +3,6 % | 1 | 5.358.425 $ | +2.620.740 $ | +95,7 % | 1 | ||||
| Protagonist Therapeutics, Inc | PTGX | → 0 | Neutral | 4.803.700 $ | +1.615.060 $ | +50,7 % | 1 | ||||||||
| uniQure N.V. | QURE | → 0 | Schwach | 4.595.353 $ | +3.219.517 $ | +234,0 % | 1 | ||||||||
| ACADIA PHARMACEUTICALS INC | ACAD | → 0 | Neutral | 4.567.410 $ | +918.270 $ | +25,2 % | 1 | ||||||||
| Solid Biosciences Inc. | SLDB | → 0 | Schwach | 4.507.056 $ | +525.470 $ | +13,2 % | 1 | ||||||||
| 95.917.627 $ | +7.781.551 $ | +15,5 % | 10 | 88.990.498 $ | +32.382.397 $ | +103,9 % | 9 | 58.366.348 $ | +17.772.939 $ | +85,3 % | 6 | ||||